Scinai Immunotherapeutics (SCNI) Shares Outstanding (Diluted Average) (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $9.3 billion as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 189.55% to $9.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 billion through Dec 2025, up 189.55% year-over-year, with the annual reading at $9.3 billion for FY2025, 189.55% up from the prior year.
- Shares Outstanding (Diluted Average) hit $9.3 billion in Q4 2025 for Scinai Immunotherapeutics, up from $3.2 billion in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $9.3 billion in Q4 2025 to a low of $3.2 billion in Q4 2024.